AG
USNA icon

Aperio Group’s Usana Health Sciences USNA Stock Holding History

Aperio Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$611K Sell
7,929
-140
-2% -$10.8K ﹤0.01% 1862
2020
Q3 		$594K Buy
8,069
+301
+4% +$24.1K ﹤0.01% 1721
2020
Q2 		$570K Sell
7,768
-217
-3% -$17K ﹤0.01% 1715
2020
Q1 		$461K Sell
7,985
-2,006
-20% -$140K ﹤0.01% 1693
2019
Q4 		$785K Buy
9,991
+203
+2% +$15K ﹤0.01% 1569
2019
Q3 		$669K Sell
9,788
-6,461
-40% -$434K ﹤0.01% 1602
2019
Q2 		$1.29M Sell
16,249
-4,543
-22% -$360K 0.01% 1260
2019
Q1 		$1.74M Sell
20,792
-2,361
-10% -$246K 0.01% 1089
2018
Q4 		$2.73M Sell
23,153
-3,868
-14% -$447K 0.01% 866
2018
Q3 		$3.26M Sell
27,021
-1,336
-5% -$166K 0.01% 830
2018
Q2 		$3.27M Buy
28,357
+3,028
+12% +$331K 0.02% 813
2018
Q1 		$2.18M Buy
25,329
+2,780
+12% +$215K 0.01% 961
2017
Q4 		$1.67M Buy
22,549
+9,411
+72% +$629K 0.01% 1059
2017
Q3 		$758K Buy
13,138
+1,653
+14% +$97.7K ﹤0.01% 1437
2017
Q2 		$736K Buy
11,485
+1,149
+11% +$70.8K ﹤0.01% 1407
2017
Q1 		$595K Buy
10,336
+5,644
+120% +$337K ﹤0.01% 1441
2016
Q4 		$287K Buy
4,692
+278
+6% +$18.1K ﹤0.01% 1817
2016
Q3 		$305K Buy
4,414
+496
+13% +$32.7K ﹤0.01% 1700
2016
Q2 		$218K Buy
3,918
+442
+13% +$26.7K ﹤0.01% 1821
2016
Q1 		$211K Buy
3,476
+90
+3% +$5.3K ﹤0.01% 1846
2015
Q4 		$216K Buy
3,386
+340
+11% +$22.1K ﹤0.01% 1788
2015
Q3 		$204K Buy
3,046
+6
+0.2% +$424 ﹤0.01% 1760
2015
Q2 		$208K Buy
+3,040
New +$193K ﹤0.01% 1839

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aperio Group's USNA Position: Q4 2020 in Review

Aperio Group reduced its Usana Health Sciences (USNA) stake by 1.7% in Q4 2020, selling an estimated $10.8K and leaving 7,929 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Aperio Group first reported a position in USNA in Q2 2015 and has held it in 23 quarters since. The position peaked at $3.27M in Q2 2018. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2020.

  • Aperio Group held 7,929 shares of Usana Health Sciences worth $611K as of Q4 2020.
  • Aperio Group sold 140 Usana Health Sciences shares in Q4 2020, an estimated $10.8K.
  • Usana Health Sciences made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1862 holding.
  • Aperio Group first reported a position in Usana Health Sciences in Q2 2015 and has held it in 23 quarters since.
  • Aperio Group's Usana Health Sciences position peaked at $3.27M in Q2 2018.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.